Exhibit 99.1 Monogram Orthopaedics Reports First Quarter 2024 Financial Results Verification and Validation Testing Expected to be Largely Complete in Q2 2024; 510(k) Submission with FDA Accelerated for Second Half of 2024 Engaged Contract Research Organization to Oversee mBôs Robot Clinical Trial Activities Outside the U.S. Management to Host Business Update Conference Call on Wednesday, May 22 at 4:30 p.m. Eastern Time AUSTIN, TX – May 14, 2024 - Monogram Orthopaedics Inc. (NASDAQ:MGRM) ("Monogram" or the ...